无症状脑膜瘤主动伽玛刀手术与无干预自然病程的临床与影像学结局比较
该研究回顾了2006年1月至2017年5月354例新诊断无症状脑膜瘤患者,分为伽玛刀手术组(n=153)和观察组(n=201),比较临床与影像学进展率及体积变化。结果显示伽玛刀手术组临床和影像学进展率均显著低于观察组,但伽玛刀手术组有13.3%发生不良事件,其中0.5%需显微手术。作者认为主动伽玛刀手术可能是合理的治疗选择。
要点
- 伽玛刀手术组临床进展4例(2.6%),观察组73例(36.3%),p<0.001。
- 伽玛刀手术组影像学肿瘤控制率94.1%,观察组影像学进展141例(70.1%)。
- 伽玛刀手术组不良事件26/195例(13.3%),其中1例(0.5%)需显微手术。
核心结论
- 无症状脑膜瘤是良性病变,但近三分之二患者出现肿瘤生长,三分之一未治疗患者在观察等待期间最终需要神经外科干预。
- 伽玛刀手术能以高概率实现临床和影像学肿瘤控制。
- 尽管存在一过性不良事件风险,当无限制预期寿命的合并症时,主动伽玛刀手术可能是合理的治疗选择。
研究设计与样本
- 回顾性分析2006年1月至2017年5月新诊断的无症状脑膜瘤患者354例,分为伽玛刀手术组(n=153)和观察组(n=201)。
- 检查临床和影像学进展率,并分析体积变化。
主要发现
- 临床进展(临床医生判断的进展,包括症状性进展n=43和常规影像判断的尺寸增大n=34)在伽玛刀手术组发生4例(2.6%),观察组73例(36.3%),p<0.001。
- 临床无进展生存率在伽玛刀手术组和观察组5年分别为98.7%和64.6%(p<0.001),10年分别为92.9%和42.7%(p<0.001)。
- 影像学肿瘤控制率在伽玛刀手术组为94.1%,观察组影像学进展141例(70.1%)。
- 影像学无进展生存率在伽玛刀手术组和观察组5年分别为94.4%和38.5%(p<0.001),10年分别为88.5%和7.9%(p<0.001)。
- 观察组中年轻年龄、无钙化、瘤周水肿和高T2信号强度与临床进展相关。
临床怎么用
- 作者认为,当无限制预期寿命的合并症时,主动伽玛刀手术可能是合理的治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to verify the effect of proactive Gamma Knife surgery (GKS) in the treatment of asymptomatic meningioma compared with the natural course without any therapeutic intervention. METHODS: From January 2006 to May 2017, 354 patients newly diagnosed with asymptomatic meningioma were reviewed and categorized into GKS (n = 153) and observation (n = 201) groups. Clinical and radiological progression rates were examined, and changes in volume were analyzed. RESULTS: Clinical progression (i.e., clinician-judged progression), combining symptomatic progression (n = 43) and clinician-judged increase in size using images routinely acquired (n = 34), occurred in 4 patients (2.6%) and 73 patients (36.3%) in the GKS and observation groups, respectively (p < 0.001). The clinical progression-free survival (PFS) rates in the GKS and observation groups were 98.7% and 64.6%, respectively, at 5 years (p < 0.001), and 92.9% and 42.7%, respectively, at 10 years (p < 0.001). The radiological tumor control rate was 94.1% in the GKS group, and radiological progression was noted in 141 patients (70.1%) in the observation group. The radiological PFS rates in the GKS and observation groups were 94.4% and 38.5%, respectively, at 5 years (p < 0.001), and 88.5% and 7.9%, respectively, at 10 years (p < 0.001). Young age, absence of calcification, peritumoral edema, and high T2 signal intensity were correlated with clinical progression in the observation group. Volumetric analysis showed that untreated tumors gradually increased in size. However, GKS-treated tumors shrank gradually, although transient volume expansion was observed in the first 6 months. Adverse events developed in 26 of the 195 GKS-treated patients (13.3%), including 1 (0.5%) major event requiring microsurgery due to severe edema after GKS. Peritumoral edema was related to the development of adverse events (p = 0.004). CONCLUSIONS: Asymptomatic meningioma is a benign disease; however, nearly two-thirds of patients experience tumor growth and one-third of untreated patients eventually require neurosurgical interventions during watchful waiting. GKS can control tumors clinically and radiologically with high probability. Although the risk of transient adverse events exists, proactive GKS may be a reasonable treatment option when there are no comorbidities limiting life expectancy.
引用
- Kim KH, Kang SJ, Choi JW, et al. Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention. J Neurosurg. 2018. PMID: 29775154. doi:10.3171/2017.12.JNS171943
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。